¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Y44"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
Y44
Agents primarily affecting blood constituents
ÀÏÂ÷ÀûÀ¸·Î Ç÷¾×¼ººÐ¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦
Y44.3
Anticoagulant antagonists, vitamin K and other coagulants
Ç×ÀÀ°í¼º ´ëÇ×Á¦(±æÇ×Á¦), ºñŸ¹Î K ¹× ±âŸ ÀÀ°íÁ¦
Y44.2
Anticoagulants
Ç×ÀÀ°íÁ¦
Y44.4
Antithrombotic drugs [platelet-aggregation inhibitors]
Ç×Ç÷ÀüÁ¦[Ç÷¼ÒÆÇ ÀÀÁý ¾ïÁ¦Á¦]
Y44.0
Iron preparations and other anti- hypochromic-anaemia preparations
ö ÈÇÕ¹° ¹× ±âŸ Ç×ÀúÇ÷»ö¼Ò¼º ºóÇ÷ Á¦Á¦
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½